Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Drug Discount Agreements Pursuant To Section 130a Para. 8 Sgb V Within The Framework Of Open House Procedures 2026-03-06
Germany Pharmaceutical Discount Contracts From 01.11.2025 On Various Active Ingredients As Part Of An Open House Procedure 2026-03-07
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2026-03-07
Norway Request For Information For 9405 Surgical And Examination Lamps And 9430 Call-off Centres - The Hospital Projects In Oslo. 2026-03-07
Germany Pharmaceutical Discount Contracts From 01.11.2025 On Various Active Ingredients In The Context Of An Openhouse Process 2026-03-08
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Abirateron In The Effectiveness 500mg And The Pack Size 90st. 2026-03-08
Germany Open House Original Discount Contracts 202526 Ponesimod 2026-03-08
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Medicines With The Active Ingredient Tocilizumab (atccode 2026-03-09
Bulgaria Dynamic Purchases/ Dsp/ Public Procurement Act/ Ppa/ Subject: Delivery Of Medicinal Products For The Needs Of Mbal-svilengrad Eood 2026-03-09
Germany Open House Biologika Discount Contracts 2025-26-insulin Lispro (atc: A10ab04, Effectiveness: 100 U/ml) 2026-03-09
Whats app